News | September 27, 2024
Alembic receives USFDA final approval for Paliperidone ER tablets
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Stable profits, low leverage to keep credit profiles comfortable
This license will enable Abbott to enhance access to this novel therapy to more patients across India
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of USD 20 million in the U.S.
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
He has been associated with Caplin Steriles Ltd., Mylan Laboratories Ltd., Caplin Point Laboratories Ltd., Strides Arcolab Ltd. and Novartis Vaccines and Diagnostics
Subscribe To Our Newsletter & Stay Updated
